High-Risk Behaviors and Hospitalizations Among Gamma Hydroxybutyrate (GHB) Users |
| |
| Authors: | Susan Y. Kim Ilene B. Anderson Jo Ellen Dyer Judith C. Barker Paul D. Blanc |
| |
| Affiliation: | 1. California Poison Control System, Department of Clinical Pharmacy, University of California, San FranciscoUSAsusank@calpoison.org;3. California Poison Control System, Department of Clinical Pharmacy, University of California, San FranciscoUSA;4. Department of Anthropology, History, Social Medicine, University of California, San Francisco, California, USA;5. Department of Medicine, University of California, San Francisco, California, USA |
| |
| Abstract: | Introduction: Little is known about behaviors linked to gamma hydroxybutyrate (GHB) morbidity. Methods: We surveyed 131 GHB users, using logistic regression to test the associations between the high risk behaviors and hospital treatment for GHB (26 [20%] of subjects). Results: Increased risk of GHB hospital treatment was associated with: co-ingestion of ethanol (OR 5.2; 95% CI 1.7–16), driving under the influence of GHB (OR 3.2; 95%, CI 1.3–7.8),use of GHB to treat withdrawal symptoms (OR 2.9; 95% CI 1.1–7.9), and co-ingestion of ketamine (OR 2.7; 95% CI 1.1–6.7). Conclusion: Targeted prevention activities could focus on selected high-risk behaviors. |
| |
| Keywords: | Gamma hydroxybutyrate GHB high-risk behaviors hospitalization |
|
|
